INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 15, 2024

Primary Completion Date

June 14, 2026

Study Completion Date

December 14, 2026

Conditions
Small Cell Lung Cancer
Interventions
DRUG

iNK cells

Intravenous infusion of iNK cells is given to the subject, 5\*108 to 1\*109 cells/dose, three doses per week, a total of 6 doses. And then 1\*109 cells/dose, one doses every 4 weeks , a total of 5 doses.

Trial Locations (1)

261000

Weifang People's Hospital, Weifang

All Listed Sponsors
collaborator

Weifang People's Hospital

OTHER

lead

Guangzhou Ruixin Biotechnological Co., LTD

INDUSTRY